Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Files

Download

Download Full Text (1.2 MB)

Description

The goal of this research project is to identify and characterize potentially novel antineoplastic agents that could specifically degrade conformational mutP53 protein in cancer cells. We concluded that treatment of cancer cells with curcumin or PLINH compounds inhibit proliferation of cancer cells in a DNAJA1-misfolded mutp5-dependent manner. Delineation of the exact mechanism through which curcumin and PLINH exert their anti-cancer effects could pave the way for promising novel preventive and therapeutic modalities for cancer.

Publication Date

5-2019

Keywords

PLINH; mutP53

MeSH Keywords

Tumor Suppressor Protein p53; Curcumin; Plumbagin; Isoniazid; Antineoplastic Agents

Disciplines

Medical Genetics | Neoplasms | Oncology | Translational Medical Research

When and Where Presented

Children's Mercy Kansas City Research Days, May 2019

Mutant p53 Depletion by Natural Compounds

Share

COinS